Plasma Derived Therapy Market | Staying Up to Date with New Development Plans for 2035
The global plasma derived therapy market has demonstrated steady expansion, reflecting its critical role in treating rare and chronic conditions. The market was valued at USD 24.31 billion in 2025 and is projected to reach USD 48.27 billion by 2035, registering a compound annual growth rate (CAGR) of 7.1% during the forecast period (2026–2035). This growth trajectory is supported by increasing therapeutic applications, rising diagnosis rates of immune-related disorders, and expanding plasma collection infrastructure worldwide.
